SE0004671D0 - Pharmaceutical formulation - Google Patents
Pharmaceutical formulationInfo
- Publication number
- SE0004671D0 SE0004671D0 SE0004671A SE0004671A SE0004671D0 SE 0004671 D0 SE0004671 D0 SE 0004671D0 SE 0004671 A SE0004671 A SE 0004671A SE 0004671 A SE0004671 A SE 0004671A SE 0004671 D0 SE0004671 D0 SE 0004671D0
- Authority
- SE
- Sweden
- Prior art keywords
- formulation
- pharmaceutical formulation
- erasable
- drug
- dissolved
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000003628 erosive effect Effects 0.000 abstract 1
- 238000013265 extended release Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0004671A SE0004671D0 (sv) | 2000-12-15 | 2000-12-15 | Pharmaceutical formulation |
| US09/788,414 US20020114831A1 (en) | 2000-12-15 | 2001-02-21 | Pharmaceutical formulation |
| US10/342,222 US7338667B2 (en) | 2000-12-15 | 2003-01-15 | Pharmaceutical formulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0004671A SE0004671D0 (sv) | 2000-12-15 | 2000-12-15 | Pharmaceutical formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0004671D0 true SE0004671D0 (sv) | 2000-12-15 |
Family
ID=20282266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0004671A SE0004671D0 (sv) | 2000-12-15 | 2000-12-15 | Pharmaceutical formulation |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US20020114831A1 (sv) |
| SE (1) | SE0004671D0 (sv) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
| PA8578501A1 (es) * | 2002-07-25 | 2005-02-04 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
| US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
| SG164375A1 (en) * | 2004-08-13 | 2010-09-29 | Boehringer Ingelheim Int | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| DE602005024570D1 (de) * | 2004-08-13 | 2010-12-16 | Boehringer Ingelheim Pharma | Tablettenformulierung mit verlängerter freisetzung mit pramipexol oder einem pharmazeutisch zulässigen salz davon, herstellungsverfahren und verwendung dafür |
| US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
| EP1830886B1 (en) * | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| BRPI0608780A2 (pt) * | 2005-04-28 | 2010-11-09 | Eisai R&D Man Co Ltd | composição contendo fármaco anti-demência |
| US20090041844A1 (en) * | 2006-02-10 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Modified Release Formulation |
| WO2007090883A1 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Extended release formulation |
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| KR20090109130A (ko) * | 2007-02-09 | 2009-10-19 | 포니아드 파마슈티칼즈, 인크. | 캡슐화된 피코플라틴 |
| US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
| US20080268067A1 (en) * | 2007-03-09 | 2008-10-30 | Llinas Rodolfo R | Methods and Compositions for Treating Thalamocortical Dysrhythmia |
| TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
| US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
| US20100310661A1 (en) * | 2007-07-16 | 2010-12-09 | Poniard Pharmaceuticals, Inc. | Oral formulations for picoplatin |
| EP2249827A4 (en) * | 2008-02-08 | 2012-05-30 | Poniard Pharmaceuticals Inc | USE OF PICOPLATIN AND CETUXIMAB IN THE TREATMENT OF COLORECTAL CANCER |
| US8986739B2 (en) | 2011-02-28 | 2015-03-24 | Nicholas V. Perricone | Treatment of urinary incontinence using nitrone spin traps |
| CN113750069B (zh) * | 2021-11-09 | 2022-03-01 | 北京联嘉医药科技开发有限公司 | 一种硝苯地平缓释片及其制备方法 |
| CN114432254B (zh) * | 2021-12-30 | 2023-05-16 | 南通联亚药业股份有限公司 | 一种硝苯地平控释片 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8601624D0 (sv) * | 1986-04-11 | 1986-04-11 | Haessle Ab | New pharmaceutical preparations |
| US5451409A (en) | 1993-11-22 | 1995-09-19 | Rencher; William F. | Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends |
| US5460826A (en) * | 1994-06-27 | 1995-10-24 | Alza Corporation | Morphine therapy |
| NZ270439A (en) * | 1995-02-02 | 1996-04-26 | Bernard Charles Sherman | Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer |
| JP3220373B2 (ja) | 1995-11-28 | 2001-10-22 | バイエル薬品株式会社 | 持続性ニフエジピン製剤 |
| EP0852141A1 (en) | 1996-08-16 | 1998-07-08 | J.B. Chemicals & Pharmaceuticals Ltd. | Nifedipine containing pharmaceutical extended release composition and a process for the preparation thereof |
| ID23503A (id) | 1997-07-01 | 2000-04-27 | Pfizer | Garam-garam sertralina dan bentuk-bentuk sediaan lepas-lambat dari sertralina |
| US6555139B2 (en) * | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
-
2000
- 2000-12-15 SE SE0004671A patent/SE0004671D0/sv unknown
-
2001
- 2001-02-21 US US09/788,414 patent/US20020114831A1/en not_active Abandoned
-
2003
- 2003-01-15 US US10/342,222 patent/US7338667B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20020114831A1 (en) | 2002-08-22 |
| US7338667B2 (en) | 2008-03-04 |
| US20030108606A1 (en) | 2003-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0004671D0 (sv) | Pharmaceutical formulation | |
| CY1116023T1 (el) | Μορφες φαρμακευτικης δοσολογιας παρατεταμενης απελευθερωσης με περιγραμματα διαλυτοποιησης ελαχιστοποιημενης εξαρτησης απο το ph | |
| ATE238813T1 (de) | Wirkstoffformulierungen mit verzögerter freisetzung | |
| DK1183014T3 (da) | Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse | |
| AR027091A1 (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| ATE244556T1 (de) | Biologisch abbaubare ph/thermosensitive hydrogele zur verzörgerten freisetzung biologisch aktiver stoffe | |
| PA8458101A1 (es) | Formas de dosificacion farmaceuticas solidas | |
| CU23440B7 (es) | Composición de liberación sostenida de pramipexol | |
| AR042536A1 (es) | Dispersiones solidas que comprenden un farmaco higroscopico y/o delicuescente | |
| NO2013019I2 (no) | Aliskiren eller et farmasøytisk akseptabelt salt derav, og hydroklortiazid eller et farmasøytisk akseptabelt salt derav. | |
| AR048250A1 (es) | Productos de pelicula que tienen propiedades de disgregacion controlada | |
| CL2004000837A1 (es) | Pelicula ingerible para adherirse y disolverlo en la cavidad oral, que comprende un polimero soluble en agua, un enmascarador de sucralosa y un agente farmaceuticamente activo. | |
| AR003908A1 (es) | Tableta de liberacion controlada | |
| PA8548801A1 (es) | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco | |
| ATE314054T1 (de) | Osmotisches verabreichungssystem für lösliche dosen | |
| GR3030732T3 (en) | Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent. | |
| ES2151464T1 (es) | Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla. | |
| ECSP044974A (es) | Formulación de suspensión oral estabilizada | |
| EE9900589A (et) | Farmatseutilised kompositsioonid limaskestale kandmiseks | |
| DK0950403T3 (da) | Emulsioner til in-situ leveringssystemer | |
| MY130332A (en) | Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer | |
| IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
| AR032642A1 (es) | Composiciones quimioterapicas de paclitaxel en microemulsion con mayor biodisponibilidad oral. | |
| DE60041691D1 (de) | Ph-unabhängige pharmazeutische formulierungen mit verlängerter freisetzung | |
| SE0001916D0 (sv) | Novel formulation |